Here's What UBS Thinks About Eli Lilly and Company (LLY) [Yahoo! Finance]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Yahoo! Finance
coverage of Eli Lilly and Company (NYSE:LLY) with a Buy rating and raised the price target from $1,080 to $1,250. The analyst noted the company's leadership in the obesity treatment market as one of the key factors behind his bullish sentiment. The firm highlighted that the company's performance in 2026 would be driven by the anticipated approval of obesity drug Orfo. The approval of the drug seems imminent as Eli Lilly and Company (NYSE:LLY) filed for regulatory approval in early December. The firm also believes that the approval could lead the company to exceed Wall Street's consensus estimates for 2026-2028. Moreover, UBS also cited that Medicare coverage for obesity treatments is expected to begin in 2026. This coverage is anticipated to help the company boost adoption of its approved and upcoming obesity treatments. That said, earlier on January 5, Leerink Partners also raised the price target on the stock from $1,104 to $1,234 and maintained a Buy rating. Leerink Partners al
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- ???????2026???Drugs to Watch??????????????????????????11???? [CNET News]CNET News
- Amgen to announce data on obesity drug MariTide at healthcare conference [Yahoo! Finance]Yahoo! Finance
- Pfizer CEO plans for soaring consumer market for obesity drugs akin to Viagra [Yahoo! Finance]Yahoo! Finance
- What are GLP-3s? Meet the new generation of weight-loss drugs with three key ingredients [FOX News]FOX News
- This Healthcare Stock Could Be One of the Best Companies to Own in 2026 [Yahoo! Finance]Yahoo! Finance
LLY
Earnings
- 10/30/25 - Beat
LLY
Sec Filings
- 1/8/26 - Form 4
- 1/6/26 - Form 3
- 1/6/26 - Form 4
- LLY's page on the SEC website